DISSECTING DISEASE-SPECIFIC DIFFERENCES IN RA AND OA BY TRANSCRIPTOME ANALYSES OF SYNOVIAL TISSUE, BLOOD AND BONE MARROW MONOCYTES Biljana Smiljanovic.

Slides:



Advertisements
Similar presentations
Background Rheumatoid Arthritis (RA) is a polygenic disease characterised by localised joint destruction and osteoporosis. The pathogenesis of RA is not.
Advertisements

Immune Activation/Inflammation and HIV Disease Prof. Georg Behrens Department for Clinical Immunology and Rheumatology Hannover Medical School Germany.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ZULEYHA OZEN.
Rheumatoid Arthritis(RA)
Background and Objective:Materials and Methods: Results: Conclusion: Samples were collected before Methotrexate treatment. The transcriptomes were determined.
Automated analysis of cytometric profiles of synovial fluid and peripheral blood in rheumatoid arthritis Till Sörensen 1, Ursula Schulte-Wrede 2, Silvia.
KRISTEN DOSTIE Alteration of Chemotaxis in the Gut of IBD Patients.
Knee Aspiration. Knee Aspiration Knee Infections Synovial fluid: Normal:
Acknowledgement: BTCure IMI grant agreement no ArthroMark grant no 01EC1009A Identification of co-expression networks of inflammatory response.
Cell-specific type I Interferon signatures in autoimmunity and viral infection: what makes the difference? Chieko Kyogoku 1, Biljana Smiljanovic 1, Joachim.
OUTCOME MEASURES IN PsA: TISSUE ANALYSIS Oliver FitzGerald.
Kara Kliethermes Jim Shinaberry December 6, 2012.
SYNOVIAL TISSUE TRANSCRIPTOME AND SYNOVIAL FLUID PROTEOME HAVE STRONGER DISCRIMINATORY POWER THAN SERUM IN DISSECTING INFLAMMATION IN RHEUMATOID ARTHRITIS.
Marc Bonin Department of Rheumatology and Clinical Immunology Charité University Hospital Charitéplatz 1 D Berlin Germany Tel: +49(0)
Lectures 12 Cytokines and Immune Response September 24, 2004 Chris Schindler Reading: Janeway - as indicated Abbas - Chapter 11.
Rheumatoid Arthritis(RA) Dr. Gehan Mohamed. Learning objectives: At the end of this lecture the student should be able to : understand definition,genetic.
Comparative analysis between Rheumatoid arthritis and arthritis model – study of the functional components in expression profiles of synovitis Irene Ziska.
Identification of gene co-expression networks associated with different cellular and immunological states Marc Bonin 1, Jekaterina Kokatjuhha 1, Stephan.
Physiological Diseases of the human Skeleton. Inflammatory Disorders of joints Joint pain and discomfort can be caused by many factors Bursitis Arthritis.
Th17 and Treg in RA Seong Wook Kang Division of Rheumatology Department of Internal Medicine Chnungnam National University School of Medicine.
A clinical database for networking in multicenter studies Ulrike Haase 1, Marc Bonin 1, Stephan Flemming 2, Frank Buttgereit 1, Till Sörensen 1, Thomas.
Identification of co-expression networks by comparison of a multitude of different functional states of genome activity Marc Bonin 1, Stephan Flemming.
BIOCONPAGES Comparison of DNA-methylation and gene expression in different immune cells Marc Bonin 1, Lorette Weidel 1, Pascal Schendel 1, Sascha Johannes.
 Gene-expression profiles from synovial tissue biopsies and blood monocytes were generated from patients with RA and OA.  Transcriptome analysis of synovial.
OUTCOME MEASURES IN PsA: IMMUNOHISTOLOGY Oliver FitzGerald.
A, miR-146a levels in spleen, bone marrow and paw from K/BxN serum-transfer (day 1, 2, 3 and 10) and hTNFtg arthritis (week 6,8 and10) diseased mice, measured.
Air Pouch Inflammation model
Rheumatology Normal Anatomy andPhysiology. Synovial joints: Normal Anatomy 1. Bone: 2. Cartilage: 3. Synovium:
RHEUMATOLOGY TESTING Maureen Sestito, D.O. PCOM Internal Medicine Residency.
BY Mahsa Asadbeik In the Name of God. Introduction Signaling, Cellular Sources, and Biological Activities IL-17 cytokines and receptors family IL-17 in.
Richard C. Chou, Nancy D. Kim, Christian D. Sadik, Edward Seung, Yinan Lan, Michael H. Byrne, Bodduluri Haribabu, Yoichiro Iwakura, Andrew D. Luster Lipid-Cytokine-Chemokine.
Serum Dickkopf-1 ( DKK-1) and Arthritis in Systemic Lupus Erythematosus Patients S. I. Nasef, H. H. Omar Samah Ismail Nasef MD, MRCP Rheumatology UK Lecturer.
Eynav Kliger Pharmaceutical R&D process  The average time of drug development years  The average probability of success in the cardiovascular.
Introduction to collagen-vascular diseases. Definition: Rheumatologic (or Rheumatic) Disease: diseases characterized by pain and inflammation in joints.
Combined analysis of DNA-methylation and transcription profiles in different immune cells identifies hot spots of gene regulation by DNA methylation Marc.
C-Reactive Protein (CRP). CRP CRP is a serologic test which is used for diagnosis of Inflammations and Infections. CRP was so named because it was first.
4. Rheumatologic conditions
High-throughput genomic profiling of tumor-infiltrating leukocytes
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Immunology in Rheumatic Diseases
Cytokine and chemokine responses as predictive markers for distinct stages of Alveolar Echinococcosis X. Huang1, C.J. Lechner1, B. Grüner2, W.H. Hoffmann1,
Th17 and Treg in RA Seong Wook Kang Division of Rheumatology
Fig. 1. Percentage of patients with AS, with RA and of normal controls responding to the in vitro stimulation with the G1 domain of the proteoglycan aggrecan.
B-CELL SUBSETS DIFFERENCES IN INFLAMMATORY RHEUMATIC DISEASES
Andrew E. Williams. , Ricardo J. José, Paul F. Mercer, Jeremy S
Sidra Hussain, Priyanka Sivakumaran Coziana Ciurtin
Figure 1 Lymphocytes during the disease
Immunologic effects of F16-IL2 therapy.
Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes  K.L.E.
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
ARTHRITIS A number of diseases that result in the destruction of articular cartilage.
Figure 3 Transcriptome studies performed in the target
Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome 
Acute inflammation with induction of anaphylatoxin C5a and terminal complement complex C5b-9 associated with multiple intra-articular injections of hylan.
Is RA Treatment Addressing the Real Needs of Patients?
2. TOLERANCE 1. Immune Mechanisms 3. Autoimmunity
Figure 2 Type 3 immunity and AS
Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal.
Figure 4 Macrophages in liver inflammation
M.J. Martínez-Calatrava, R. Largo, G. Herrero-Beaumont 
Types of biomarkers/biosignatures to be used for cardiovascular disease. Types of biomarkers/biosignatures to be used for cardiovascular disease. There.
Figure 2 GM-CSF — a key player in inflammation and autoimmunity
Figure 2 Phenotypes of osteoarthritis
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Role of chemokines in dendritic cell migration
Association of CCL2 with systemic inflammation in Schnitzler’s syndrome Karoline Krause, Robert Sabat, Ellen Witte-Händel, Anne Schulze, Viktoria Puhl,
Systemic effects of local allergic disease
How to establish the diagnosis of LGL leukemia.
A. Carlson, B. Bothner, R. June  Osteoarthritis and Cartilage 
Presentation transcript:

DISSECTING DISEASE-SPECIFIC DIFFERENCES IN RA AND OA BY TRANSCRIPTOME ANALYSES OF SYNOVIAL TISSUE, BLOOD AND BONE MARROW MONOCYTES Biljana Smiljanovic 1, Bruno Stuhlmüller 1, Wlodzimierz Maslinski 3, Gerd R. Burmester 1, Andreas Radbruch 2, Andreas Grützkau 2, Thomas Häupl 1 1 Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany 2 Deutsches Rheuma – Forschungszentrum, Berlin, Germany 3 Department of Pathophysiology and Immunology, Institute of Rheumatology, Warsaw, Poland Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with joint destruction. Joint inflammation is characterised by infiltration and activation of various immune cells. To avoid difficulties in sampling synovial tissue and to avoid fluctuation in cellular composition of leukocytes, which accompanies inflammation both in synovial tissue and blood, this study was focused on transcriptome analyses of synovial tissues, blood and bone marrow monocytes. The main aim was to analyse potential of blood monocytes in dissecting inflammation in RA and in reflecting inflammation that is evident in synovial tissue. Osteoarthritis (OA), a non-inflammatory disease, was used as control in this study. Conclusion: Materials and Methods : Background: 6 RA patients 6 OA patients 10 RA patients 10 OA patients sCD163 ***p< *p= *p= ***p< sCD163 p= **p= p= ***p= Results: 2.From monocyte transcriptomes to validation at the protein level in synovial fluid and serum from RA and OA patients 1.Transcriptomes generated from synovial tissue biopsies (A), blood monocytes (B) and bone marrow monocytes (C) discriminated RA from OA patients sCD14 SYNOVIAL FLUID (SF)SERUM sCD14, sCD163, TNFAIP6 and IL1R2 as potential markers that discriminated RA from OA were measured in Synovial fluid and Serum sCD14, sCD163 and IL1R2 measured in SF showed differences between RA and OA, while in serum only sCD14 exhibited difference. (A) TRANSCRIPTOME OF SYNOVIAL TISSUE (2019 AFFYMETRIX IDS) (B) TRANSCRIPTOME OF BLOOD MONOCYTES (379 AFFYMETRIX IDS) The RA gene expression profile was the most specific and robust in synovial tissue, demonstrating the dominance of the inflammatory process in the joints. Nevertheless, the systemic nature of RA was also evident at the level of blood and bone marrow monocytes. Concerning that blood is a favourable and easily accessible material for diagnosis and that monocytes are able to exhibit disease-specific alterations, understanding the monocyte response in different rheumatic diseases seems to be an advantageous approach for biomarker discovery. This approach should be essential for identifying the objective criteria relevant for disease and therapeutic stratification of patients with RA. Gene-expression profiles from synovial tissues biopsies were generated by Affymetrix HG-U133A arrays. Gene-expression profiles of blood and bone marrow monocytes were generated by Affymetrix HG-U133Plus arrays. The BioRetis database was used for array data analyses. Biljana Smiljanovic Department of Rheumatology and Clinical Immunology, Charité University Hospital Charitéplatz 1 D Berlin Germany (C) TRANSCRIPTOME OF BONE MARROW MONOCYTES (221 AFFYMETRIX IDS) 8 RA patients 8 OA patients Genes involved in: Inflammation (276 Affy IDs): CCL2, CCL5, CCL8, CCL13, CCL18, CXCL1, CXCL9, CXCL10, CXCL13, IL6, IL7, IL8, IL15 Cell adhesion (65 Affy IDs): ICAM1, ICAM3, ITGB2, ITGA4, SELE Extracellular matrix formation (31 Affy IDs): SDC1, SDC2, SDC3, CD44, FN1, LAMA2 Profile indicates infiltration of various cell types: Mf, T-, B-, NK- cells Genes involved in: Inflammation (40 Affy IDs): CCR2, CXCR4, IL1R2, TNFAIP6, CD163 Cell adhesion (22 Affy IDs): CD44, ICAM2, ICAM4, ITGAL Inflammatory profile in blood Mo was weaker than in synovial tissue p= sIL1R2TNFAIP6 sIL1R2TNFAIP6 **p= Genes involved in: Inflammation (18 Affy IDs): IL1R2, TNFAIP6, IL10, FAS Cell adhesion (13 Affy IDs): ITGA4, ITGA6, ITGB1, ALCAM Inflammatory profile in bone marrow Mo was far weaker than in peripheral blood Mo Funding:BTCure contract no ArthroMark grant no 01EC1009A

DISSECTING DISEASE-SPECIFIC DIFFERENCES IN RA AND OA BY TRANSCRIPTOME ANALYSES OF SYNOVIAL TISSUE, BLOOD AND BONE MARROW MONOCYTES Biljana Smiljanovic 1, Bruno Stuhlmüller 1, Wlodzimierz Maslinski 3, Gerd R. Burmester 1, Andreas Radbruch 2, Andreas Grützkau 2, Thomas Häupl 1 1 Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany 2 Deutsches Rheuma – Forschungszentrum, Berlin, Germany 3 Department of Pathophysiology and Immunology, Institute of Rheumatology, Warsaw, Poland Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with joint destruction. Joint inflammation is characterised by infiltration and activation of various immune cells. To avoid difficulties in sampling synovial tissue and to avoid fluctuation in cellular composition of leukocytes, which accompanies inflammation both in synovial tissue and blood, this study was focused on transcriptome analyses of synovial tissues, blood and bone marrow monocytes. The main aim was to analyse potential of blood monocytes in dissecting inflammation in RA and in reflecting inflammation that is evident in synovial tissue. Osteoarthritis (OA), a non-inflammatory disease, was used as control in this study. Conclusion: Materials and Methods : Background: 6 RA patients 6 OA patients 10 RA patients 10 OA patients sCD163 ***p< *p= *p= ***p< sCD163 p= **p= p= ***p= Results: 2.From monocyte transcriptomes to validation at the protein level in synovial fluid and serum from RA and OA patients 1.Transcriptomes generated from synovial tissue biopsies (A), blood monocytes (B) and bone marrow monocytes (C) discriminated RA from OA patients sCD14 SYNOVIAL FLUID (SF)SERUM sCD14, sCD163, TNFAIP6 and IL1R2 as potential markers that discriminated RA from OA were measured in Synovial fluid and Serum sCD14, sCD163 and IL1R2 measured in SF showed differences between RA and OA, while in serum only sCD14 exhibited difference. (A) TRANSCRIPTOME OF SYNOVIAL TISSUE (2019 AFFYMETRIX IDS) (B) TRANSCRIPTOME OF BLOOD MONOCYTES (379 AFFYMETRIX IDS) The RA gene expression profile was the most specific and robust in synovial tissue, demonstrating the dominance of the inflammatory process in the joints. Nevertheless, the systemic nature of RA was also evident at the level of blood and bone marrow monocytes. Concerning that blood is a favourable and easily accessible material for diagnosis and that monocytes are able to exhibit disease-specific alterations, understanding the monocyte response in different rheumatic diseases seems to be an advantageous approach for biomarker discovery. This approach should be essential for identifying the objective criteria relevant for disease and therapeutic stratification of patients with RA. Gene-expression profiles from synovial tissues biopsies were generated by Affymetrix HG-U133A arrays. Gene-expression profiles of blood and bone marrow monocytes were generated by Affymetrix HG-U133Plus arrays. The BioRetis database was used for array data analyses. Biljana Smiljanovic Department of Rheumatology and Clinical Immunology, Charité University Hospital Charitéplatz 1 D Berlin Germany (C) TRANSCRIPTOME OF BONE MARROW MONOCYTES (221 AFFYMETRIX IDS) 8 RA patients 8 OA patients Genes involved in: Inflammation (276 Affy IDs): CCL2, CCL5, CCL8, CCL13, CCL18, CXCL1, CXCL9, CXCL10, CXCL13, IL6, IL7, IL8, IL15 Cell adhesion (65 Affy IDs): ICAM1, ICAM3, ITGB2, ITGA4, SELE Extracellular matrix formation (31 Affy IDs): SDC1, SDC2, SDC3, CD44, FN1, LAMA2 Profile indicates infiltration of various cell types: Mf, T-, B-, NK- cells Genes involved in: Inflammation (40 Affy IDs): CCR2, CXCR4, IL1R2, TNFAIP6, CD163 Cell adhesion (22 Affy IDs): CD44, ICAM2, ICAM4, ITGAL Inflammatory profile in blood Mo was weaker than in synovial tissue p= sIL1R2TNFAIP6 sIL1R2TNFAIP6 **p= Genes involved in: Inflammation (18 Affy IDs): IL1R2, TNFAIP6, IL10, FAS Cell adhesion (13 Affy IDs): ITGA4, ITGA6, ITGB1, ALCAM Inflammatory profile in bone marrow Mo was far weaker than in peripheral blood Mo Funding:BTCure contract no ArthroMark grant no 01EC1009A